Valeo Financial Advisors LLC Sells 2,081 Shares of Zoetis Inc. $ZTS

Key Points

• Valeo Financial Advisors LLC reduced its holdings in Zoetis Inc. by 29.3%, selling 2,081 shares during the second quarter, leading to a total of 5,010 shares worth approximately $781,000.
• Zoetis recently reported earnings per share of $1.76, exceeding analyst expectations, with a revenue of $2.46 billion during the quarter.
• Analysts have mixed ratings for Zoetis, with five maintaining a "Buy" rating and five issuing a "Hold" rating, resulting in a consensus target price of $200.88.

Valeo Financial Advisors LLC reduced its holdings in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 29.3% in the second quarter, according to its most recent filing with the SEC. The fund owned 5,010 shares of the company's stock after selling 2,081 shares during the period. Valeo Financial Advisors LLC's holdings in Zoetis were worth $781,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Vanguard Group Inc. lifted its stake in shares of Zoetis by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 41,556,164 shares of the company's stock worth $6,842,222,000 after acquiring an additional 189,287 shares during the last quarter. Polen Capital Management LLC lifted its stake in shares of Zoetis by 17.6% during the 1st quarter. Polen Capital Management LLC now owns 8,796,847 shares of the company's stock worth $1,448,401,000 after acquiring an additional 1,313,653 shares during the last quarter. Northern Trust Corp lifted its stake in shares of Zoetis by 1.2% during the 1st quarter. Northern Trust Corp now owns 6,504,902 shares of the company's stock worth $1,071,032,000 after acquiring an additional 78,508 shares during the last quarter. Goldman Sachs Group Inc. raised its position in Zoetis by 2.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 5,146,024 shares of the company's stock valued at $847,293,000 after purchasing an additional 109,791 shares in the last quarter. Finally, Brown Advisory Inc. lifted its holdings in shares of Zoetis by 7.6% in the 1st quarter. Brown Advisory Inc. now owns 4,408,542 shares of the company's stock worth $725,866,000 after buying an additional 312,746 shares during the period. 92.80% of the stock is owned by institutional investors.

Zoetis Trading Up 0.6%

Shares of NYSE ZTS opened at $143.61 on Thursday. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. The stock has a market capitalization of $63.65 billion, a P/E ratio of 24.72, a price-to-earnings-growth ratio of 2.29 and a beta of 0.90. Zoetis Inc. has a 1-year low of $139.34 and a 1-year high of $196.55. The business has a fifty day moving average price of $149.41 and a 200 day moving average price of $154.74.

Zoetis (NYSE:ZTS - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.14. The firm had revenue of $2.46 billion during the quarter, compared to analysts' expectations of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The firm's quarterly revenue was up 4.2% on a year-over-year basis. During the same period in the prior year, the business posted $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts expect that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Argus reiterated a "buy" rating and issued a $190.00 target price on shares of Zoetis in a report on Tuesday, September 9th. Piper Sandler upped their target price on Zoetis from $210.00 to $215.00 and gave the stock an "overweight" rating in a report on Monday, August 11th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Zoetis in a report on Wednesday. Leerink Partnrs cut Zoetis from a "strong-buy" rating to a "hold" rating in a report on Thursday, July 17th. Finally, Stifel Nicolaus cut Zoetis from a "buy" rating to a "hold" rating and lowered their target price for the stock from $165.00 to $160.00 in a report on Wednesday, June 18th. Five analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $200.88.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.